Herath H M M T B, Pahalagamage S P, Yogendranathan Nilukshana, Wijayabandara M D M S, Kulatunga Aruna
National Hospital, Colombo, Sri Lanka.
BMC Pharmacol Toxicol. 2017 Jan 23;18(1):6. doi: 10.1186/s40360-016-0114-5.
Amitraz is a pesticide used worldwide on animals and in agriculture. It contains triazapentadiene, which is a centrally acting alpha-2 adrenergic agonist. Amitraz poisoning is fairly uncommon in humans and occurs via oral, dermal or inhalational routes. Only a limited number of case reports of human intoxication have been published and most of them are of accidental ingestion by children.
A twenty-year-old Sri Lankan female presented following self-ingestion of 20 ml of amitraz resulting in 37.8 mg/ kg of amitraz poisoning. She lost consciousness after 20 min of ingestion, developed bradycardia and hypotension, which needed intravenous fluid resuscitation and dobutamine. Gastric lavage was performed. Her bradycardia persisted for 36 h and she was drowsy for 48 h. She did not develop respiratory depression, convulsions or hypothermia and the urine output was normal. Arterial blood gas revealed mild respiratory alkalosis. She recovered fully within 48 h and was discharged on day 3.
The clinical manifestations of amitraz (impaired consciousness, drowsiness, vomiting, disorientation, miosis, mydriasis, hypotension, bradycardia, respiratory depression, hypothermia, generalized seizures, hyperglycemia and glycosuria) can be explained by the agonist action of amitraz on α1 and α2 receptors. Management of amitraz poisoning is still considered to be supportive and symptomatic with monitoring of nervous system, cardiovascular and respiratory systems. Activated charcoal may still be considered for treatment and the place for gastric lavage is controversial. Atropine is effective for symptomatic bradycardia and inotropic support is needed for hypotension that does not respond to fluid resuscitation. Diazepam or Lorazepam is used for convulsions and some patients may require intubation and ICU care. Several α2 adrenergic antagonists like yohimbine have been tried on animals, which have successfully reversed the effects of amitraz. Since the majority of amitraz poisoning cases are due to accidental ingestion, manufactures, regulatory authorities and national poisons control centers have a significant role to play in minimizing its occurrence.
双甲脒是一种在全球范围内用于动物和农业的杀虫剂。它含有三氮杂戊二烯,这是一种中枢性α-2肾上腺素能激动剂。双甲脒中毒在人类中相当罕见,可通过口服、皮肤接触或吸入途径发生。仅有有限数量的人类中毒病例报告发表,其中大多数是儿童意外摄入。
一名20岁的斯里兰卡女性因自行摄入20毫升双甲脒导致中毒,中毒剂量为37.8毫克/千克。摄入20分钟后她失去意识,出现心动过缓和低血压,需要静脉补液复苏和使用多巴酚丁胺。进行了洗胃。她的心动过缓持续了36小时,嗜睡了48小时。她未出现呼吸抑制、惊厥或体温过低,尿量正常。动脉血气显示轻度呼吸性碱中毒。她在48小时内完全康复,并于第3天出院。
双甲脒的临床表现(意识障碍、嗜睡、呕吐、定向障碍、瞳孔缩小、瞳孔散大、低血压、心动过缓、呼吸抑制、体温过低、全身性惊厥、高血糖和糖尿)可通过双甲脒对α1和α2受体的激动作用来解释。双甲脒中毒的治疗仍被认为是支持性和对症性的,需监测神经系统、心血管系统和呼吸系统。活性炭仍可考虑用于治疗,洗胃的作用存在争议。阿托品对症状性心动过缓有效,对于对液体复苏无反应的低血压需要使用正性肌力药物支持。地西泮或劳拉西泮用于惊厥治疗,一些患者可能需要插管和重症监护。几种α2肾上腺素能拮抗剂如育亨宾已在动物身上试验,成功逆转了双甲脒的作用。由于大多数双甲脒中毒病例是由于意外摄入,制造商、监管机构和国家毒物控制中心在尽量减少其发生方面可发挥重要作用。